In head and neck cancer, the expression level of TOX4 correlated with adverse survival probability (Fig. 6B); similar patterns of association between TOX4 expression and shorter patient survival were also seen in stomach cancer, urothelial cancer, and pancreatic cancer (Fig. S5, A–C). This evidence concerns the gene TOX4 and gastric neoplasm.